Stock Canada Nickel Completes Private Placement of Flow-Through Units & Announces Agnico Eagle as an Investor by January 4, 2024 January 4, 2024 Highlights Agnico Eagle to become a 12% shareholder Canada Nickel Company Inc. (‘ Canada Nickel… 0 FacebookTwitterPinterestEmail
Stock Sprouts Farmers Market: A Hidden Gem on the Corner of Wall and Main Street? by January 3, 2024 January 3, 2024 Most traders and investors are drawn to a smooth trend, that being a movement whose… 0 FacebookTwitterPinterestEmail
Stock Amendments to Ukraine Transaction by January 3, 2024 January 3, 2024 European Lithium Limited (ASX: EUR, FRA:PF8, OTC: EULIF) (European Lithium or the Company) refers to… 0 FacebookTwitterPinterestEmail
Stock Chris Temple: Gold Takeoff Brewing, but Uranium’s Setup Still the Best by January 3, 2024 January 3, 2024 Chris Temple, founder, editor and publisher of the National Investor, believes gold has limited downside,… 0 FacebookTwitterPinterestEmail
Stock Nickel Price 2023 Year-End Review by January 3, 2024 January 3, 2024 Nickel soared to its highest price ever in 2022, breaking through US$100,000 per metric ton… 0 FacebookTwitterPinterestEmail
Stock AI Market 2023 Year-End Review by January 3, 2024 January 3, 2024 Artificial intelligence (AI) has transformed the way people work in recent years, allowing machines to… 0 FacebookTwitterPinterestEmail
Stock Technology Shares PLUNGE to Kick Off 2024 by January 3, 2024 January 3, 2024 In this edition of StockCharts TV‘s The Final Bar, guest Mish Schneider of MarketGauge talks strength in… 0 FacebookTwitterPinterestEmail
Stock Redstone Resources by January 3, 2024 January 3, 2024 Overview The electrification transition is well underway and has spurred a growth in demand for… 0 FacebookTwitterPinterestEmail
Stock The Science and Art of Stock Market Predictions by January 2, 2024 January 2, 2024 Over the holiday, I thought a lot about predictions and how they are formed. The… 0 FacebookTwitterPinterestEmail
Stock MRNA Stock Gets an Upgrade: When is the Best Time To Buy? by January 2, 2024 January 2, 2024 Last year’s vaccine sales decline hurt Moderna’s stock (MRNA), making it one of the worst… 0 FacebookTwitterPinterestEmail
